The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks
Nephrology Dialysis Transplantation · 2026
DOI: 10.1093/ndt/gfaf252 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Heather Walker und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Multimorbidity, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VENI, Wellcome Trust, Dutch Kidney Foundation.
Abstract (Originalsprache)
Background and hypothesis Guidelines recommend using risk prediction models for predicting kidney failure in chronic kidney disease (CKD). Many people with CKD have multiple long-term conditions (multimorbidity), which influences outcomes including kidney failure and mortality. This study validated the four-variable kidney failure risk equation (KFRE) in individuals with CKD, with and without multimorbidity, comparing performance of KFRE using creatinine and cystatin C to calculate estimated glomerular filtration rate (eGFR) and updated the model to account for competing mortality risks.
Methods
Observational cohort study using research-based (UK Biobank) and population-based cohorts (Stockholm Creatinine Measurements project: SCREAM). Multimorbidity was defined as two or more long-term conditions in addition to CKD. Kidney failure was defined as long-term dialysis or kidney transplantation. KFRE performance assessment included discrimination, calibration, and overall fit at 2 and 5 years. An updated model (using the same variables as KFRE) accounting for competing mortality risks was developed and validated.
Results
14 998 of 24 489 individuals in UK Biobank (61.2%) and 30 147 of 42 902 individuals in SCREAM (70.3%) had multimorbidity. Discrimination of KFRE was good (area under curve $\ge $0.86 across eGFR equations in all cohorts, multimorbidity groups and time horizons). Kidney failure risk was under-estimated in people with multimorbidity in UK Biobank (observed/expected (O/E) ratio 1.75 at 5 years; eGFR creatinine). Conversely, calibration-in-the-large (O/E ratio) at 5 years in SCREAM was 1.05 in the multimorbidity group (eGFR creatinine). Using cystatin C compared to creatinine did not improve model performance. Cumulative incidence of death was higher with multimorbidity compared to no multimorbidity. An updated model considering competing mortality improved calibration performance over KFRE, O/E ratio 0.98 in multimorbidity group of the validation cohort (UK Biobank) at 5 years.
Conclusion
Competing mortality risk is important when predicting kidney failure, particularly for people with multimorbidity. An updated model accounting for competing mortality risk, permits improved model performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Renal and Transplant Unit, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
- Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
- General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
ORCID-Profile: Heather Walker, Juan-Jesus Carrero, Michael K Sullivan, Anne-Laure Faucon, Jennifer S Lees, Edouard L Fu, Bhautesh Dinesh Jani, Katie Gallacher, Patrick B Mark
Förderung
- VENI
- Wellcome Trust
- Dutch Kidney Foundation
Zitieren
APA
Walker, H., Carrero, J. J., Sullivan, M. K., Field, R., Faucon, A. L., Lees, J. S., Fu, E. L., Jani, B. D., Gallacher, K., & Mark, P. B. (2026). The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf252
Vancouver
Walker H, Carrero JJ, Sullivan MK, Field R, Faucon AL, Lees JS, et al. The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf252
BibTeX
@article{Walker2026,
author = {Walker, Heather and Carrero, Juan-Jesus and Sullivan, Michael K and Field, Ryan and Faucon, Anne-Laure and Lees, Jennifer S and Fu, Edouard L and Jani, Bhautesh Dinesh and Gallacher, Katie and Mark, Patrick B},
title = {The kidney failure risk equation in people with CKD and multimorbidity: the effect of competing mortality risks},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfaf252}
}
EUVIMED